Bruno Sangro
Impact in
- Hepatology top 0.01%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Hepatitis C virus research
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
Papers in
- Hepatology 268
- Hepatocellular Carcinoma Treatment and Prognosis 220
- Liver Disease and Transplantation 48
- Oncology 138
- Cancer Immunotherapy and Biomarkers 67
- Colorectal Cancer Treatments and Studies 30
- Pancreatic and Hepatic Oncology Research 28
- Co-authors
- Jesús PrìetoIgnacio MeleroMercedes IñarrairaeguiJosep M. LlovetVincenzo MazzaferroRiad SalemPeter R. GallePablo Sarobe
- Journals
- Journal of Hepatology (63 papers)Journal of Clinical Oncology (45 papers)Annals of Oncology (22 papers)Hepatology (14 papers)Cancer Research (10 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Bruno Sangro
394 papers receiving 25.6k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Hepatology 16.2k
- Oncology 7.6k
- Epidemiology 8.4k
- Cancer Research 3.5k
- Pathology and Forensic Medicine 2.9k
Countries citing papers authored by Bruno Sangro
This map shows the geographic impact of Bruno Sangro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Sangro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Sangro more than expected).
Fields of papers citing papers by Bruno Sangro
This network shows the impact of papers produced by Bruno Sangro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Sangro. The network helps show where Bruno Sangro may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruno Sangro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | Combination immunotherapy for hepatocellular carcinoma Hit paper breakdown → | 2023 | 179 |
| 6 | 2023 | 8 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 75 | |
| 9 | 2022 | 26 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 32 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 28 | |
| 15 | 2017 | 190 | |
| 16 | 2014 | 204 | |
| 17 | 2013 | 81 | |
| 18 | 2010 | 151 | |
| 19 | 2009 | 46 | |
| 20 | 2005 | 5 |
About Bruno Sangro
Bruno Sangro is a scholar working on Hepatology, Oncology, Epidemiology, Transplantation and Pulmonary and Respiratory Medicine, having authored 416 papers that have together received 26.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (220 papers), Liver Disease Diagnosis and Treatment (83 papers), Cancer Immunotherapy and Biomarkers (67 papers), Liver Disease and Transplantation (48 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (39 papers), Hepatitis B Virus Studies (38 papers), Colorectal Cancer Treatments and Studies (30 papers) and Pancreatic and Hepatic Oncology Research (28 papers). The work is most often cited by research in Hepatology (16.2k citations), Oncology (7.6k citations), Epidemiology (8.4k citations), Cancer Research (3.5k citations) and Pathology and Forensic Medicine (2.9k citations). Bruno Sangro has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Jesús Prìeto, Ignacio Melero, Mercedes Iñarrairaegui, Josep M. Llovet, Vincenzo Mazzaferro, Riad Salem, Peter R. Galle, Pablo Sarobe, José Ignacio Bilbao and Jordi Bruix. Their work appears in journals such as Journal of Hepatology, Journal of Clinical Oncology, Annals of Oncology, Hepatology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.